These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36868388)

  • 1. A meta-analytic investigation of cognitive remediation for mood disorders: Efficacy and the role of study quality, sample and treatment factors.
    Goldberg Z; Kuslak B; Kurtz MM
    J Affect Disord; 2023 Jun; 330():74-82. PubMed ID: 36868388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors.
    Lejeune JA; Northrop A; Kurtz MM
    Schizophr Bull; 2021 Jul; 47(4):997-1006. PubMed ID: 33772310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment to Enhance Cognition in Bipolar Disorder (TREC-BD): Efficacy of a Randomized Controlled Trial of Cognitive Remediation Versus Active Control.
    Lewandowski KE; Sperry SH; Cohen BM; Norris LA; Fitzmaurice GM; Ongur D; Keshavan MS
    J Clin Psychiatry; 2017; 78(9):e1242-e1249. PubMed ID: 29045770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial of Interpersonal and Social Rhythm Therapy and group-based Cognitive Remediation versus Interpersonal and Social Rhythm Therapy alone for mood disorders: study protocol.
    Douglas KM; Inder ML; Crowe MT; Jordan J; Carlye D; Lacey C; Beaglehole B; Mulder R; Eggleston K; Donovan KA; Frampton CMA; Bowie CR; Porter RJ
    BMC Psychiatry; 2022 Feb; 22(1):115. PubMed ID: 35164720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive rehabilitation for improving cognitive functions and reducing the severity of depressive symptoms in adult patients with Major Depressive Disorder: a systematic review and meta-analysis of randomized controlled clinical trials.
    Mokhtari S; Mokhtari A; Bakizadeh F; Moradi A; Shalbafan M
    BMC Psychiatry; 2023 Jan; 23(1):77. PubMed ID: 36707847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized cognitive training and functional recovery in major depressive disorder: A meta-analysis.
    Motter JN; Pimontel MA; Rindskopf D; Devanand DP; Doraiswamy PM; Sneed JR
    J Affect Disord; 2016 Jan; 189():184-91. PubMed ID: 26437233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Remediation in Bipolar (CRiB2): study protocol for a randomised controlled trial assessing efficacy and mechanisms of cognitive remediation therapy compared to treatment as usual.
    Tsapekos D; Strawbridge R; Cella M; Goldsmith K; Kalfas M; Taylor RH; Swidzinski S; Marwaha S; Grey L; Newton E; Shackleton J; Harrison PJ; Browning M; Harmer C; Hartland H; Cousins D; Barton S; Wykes T; Young AH
    BMC Psychiatry; 2023 Nov; 23(1):842. PubMed ID: 37968619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial of psychotherapy and cognitive remediation to target cognition in mood disorders.
    Douglas KM; Groves S; Crowe MT; Inder ML; Jordan J; Carlyle D; Wells H; Beaglehole B; Mulder R; Lacey C; Luty SE; Eggleston K; Frampton CMA; Bowie CR; Porter RJ
    Acta Psychiatr Scand; 2022 Mar; 145(3):278-292. PubMed ID: 34800298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Efficacy of Cognitive Remediation in Depression: A Systematic Literature Review and Meta-Analysis.
    Thérond A; Pezzoli P; Abbas M; Howard A; Bowie CR; Guimond S
    J Affect Disord; 2021 Apr; 284():238-246. PubMed ID: 33631438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cognitive remediation on cognitive abilities and real-world functioning among people with bipolar disorder: A systematic review: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    Bellani M; Biagianti B; Zovetti N; Rossetti MG; Bressi C; Perlini C; Brambilla P
    J Affect Disord; 2019 Oct; 257():691-697. PubMed ID: 31377606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive Remediation for Outpatients With Recurrent Mood Disorders: A Feasibility Study.
    Douglas KM; Jordan J; Inder ML; Crowe MT; Mulder R; Lacey C; Beaglehole B; Bowie CR; Porter RJ
    J Psychiatr Pract; 2020 Jul; 26(4):273-283. PubMed ID: 32692124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cognitive reserve and depressive symptoms on cognitive performance in major depression and bipolar disorder.
    Ponsoni A; Damiani Branco L; Cotrena C; Milman Shansis F; Fonseca RP
    J Affect Disord; 2020 Sep; 274():813-818. PubMed ID: 32664019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study.
    Mansur RB; Ahmed J; Cha DS; Woldeyohannes HO; Subramaniapillai M; Lovshin J; Lee JG; Lee JH; Brietzke E; Reininghaus EZ; Sim K; Vinberg M; Rasgon N; Hajek T; McIntyre RS
    J Affect Disord; 2017 Jan; 207():114-120. PubMed ID: 27721184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does improvement of cognitive functioning by cognitive remediation therapy effect work outcomes in severe mental illness? A secondary analysis of a randomized controlled trial.
    Ikebuchi E; Sato S; Yamaguchi S; Shimodaira M; Taneda A; Hatsuse N; Watanabe Y; Sakata M; Satake N; Nishio M; Ito JI
    Psychiatry Clin Neurosci; 2017 May; 71(5):301-308. PubMed ID: 27873453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial.
    Ott CV; Vinberg M; Bowie CR; Christensen EM; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Sep; 19(1):487. PubMed ID: 30208971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive remediation therapy for mood disorders: rationale, early evidence, and future directions.
    Bowie CR; Gupta M; Holshausen K
    Can J Psychiatry; 2013 Jun; 58(6):319-25. PubMed ID: 23768259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study.
    Xu G; Lin K; Rao D; Dang Y; Ouyang H; Guo Y; Ma J; Chen J
    J Affect Disord; 2012 Feb; 136(3):328-39. PubMed ID: 22169253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cognitive remediation on cognitive dysfunction in partially or fully remitted patients with bipolar disorder: study protocol for a randomized controlled trial.
    Demant KM; Almer GM; Vinberg M; Kessing LV; Miskowiak KW
    Trials; 2013 Nov; 14():378. PubMed ID: 24206639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.